Gadoxetic acid-enhanced MRI and sonoelastography: Non-invasive assessments of chemoprevention of liver fibrosis in Thioacetamide-induced rats with Sho-Saiko-To

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Chen, Ya Wen ^a,b   Tsai, Meng Yuan ^c,d   Pan, Huay Ben ^c,d,e   Tseng, Hui Hwa ^c,d   Hung, Yu Ting ^c   Chou, Chen Pin ^c,d,f  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e IShou University   (Taiwan)

^f FOOYIN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GADOXETIC ACID; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; ORGANIC ANION TRANSPORTER 1; THIOACETAMIDE; XIAO CHAI HU TANG; BIOLOGICAL MARKER; CONTRAST MEDIUM; GADOLINIUM PENTETATE; HERBACEOUS AGENT; PLANT EXTRACT; SHOSAIKO-TO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; ELASTOGRAPHY; HISTOPATHOLOGY; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER FIBROSIS; LOW DRUG DOSE; MALE; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; RAT; ULTRASOUND SCANNER; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; ENZYME IMMUNOASSAY; LIVER CIRRHOSIS; LIVER FUNCTION TEST; METABOLISM; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALIA; RATTUS;

ANIMALS; BIOMARKERS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; ELASTICITY IMAGING TECHNIQUES; GADOLINIUM DTPA; IMMUNOENZYME TECHNIQUES; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; THIOACETAMIDE; TISSUE DISTRIBUTION;

EID: 84916912247     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114756     Document Type: Article

References (36)

1. Schuppan D, Kim YO (2013) Evolving therapies for liver fibrosis. J Clin Invest 123: 1887-1901.
2. Perez MJ, Suarez A, Gomez-Capilla JA, Sanchez-Medina F, Gil A (2002) Dietary nucleotide supplementation reduces thioacetamide-induced liver fibrosis in rats. J Nutr 132: 652-657.
3. Yamamoto H, Kondo M, Nakamori S, Nagano H, Wakasa K, et al. (2003) JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. Gastroenterology 125: 556-571.
4. Arda K, Ciledag N, Aktas E, Aribas BK, Kose K (2011) Quantitative assessment of normal soft-tissue elasticity using shear-wave ultrasound elastography. AJR Am J Roentgenol 197: 532-536.
5. Kato M, Liu W, Yi H, Asai N, Hayakawa A, et al. (1998) The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret-transgenic mice. J Invest Dermatol 111: 640-644.
6. Haranaka K, Satomi N, Sakurai A, Haranaka R, Okada N, et al. (1985) Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. Cancer Immunol Immunother 20: 1-5.
7. Deng G, Kurtz RC, Vickers A, Lau N, Yeung KS, et al. (2011) A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients. J Ethnopharmacol 136: 83-87.
8. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, et al. (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97: 2614-2618.
9. Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, et al. (2009) Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOBDTPA. AJR Am J Roentgenol 193: 1053-1060.
10. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO (2007) MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 6: 43-52.
11. Friedrich-Rust M, Ong MF, Herrmann E, Dries V, Samaras P, et al. (2007) Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol 188: 758-764.
12. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, et al. (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41: 48-54.
13. Sporea I, Sirli RL (2012) Hepatic elastography for the assessment of liver fibrosis-present and future. Ultraschall Med 33: 550-558.
14. Lee JK, Kim JH, Shin HK (2011) Therapeutic effects of the oriental herbal medicine Sho-saiko-to on liver cirrhosis and carcinoma. Hepatol Res 41: 825-837.
15. Chen TM, Subeq YM, Lee RP, Chiou TW, Hsu BG (2008) Single dose intravenous thioacetamide administration as a model of acute liver damage in rats. Int J Exp Pathol 89: 223-231.
16. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22: 696-699.
17. Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24: 289-293.
18. van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, et al. (1999) Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 290: 153-157.
19. Tsuda N, Matsui O (2011) Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression. Eur Radiol 21: 2542-2550.
20. Berzigotti A, Castera L (2013) Update on ultrasound imaging of liver fibrosis. J Hepatol 59: 180-182.
21. Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115: 209-218.
22. Malaguarnera G, Cataudella E, Giordano M, Nunnari G, Chisari G, et al. (2012) Toxic hepatitis in occupational exposure to solvents. World J Gastroenterol 18: 2756-2766.
23. Muller A, Machnik F, Zimmermann T, Schubert H (1988) Thioacetamide-induced cirrhosis-like liver lesions in rats-usefulness and reliability of this animal model. Exp Pathol 34: 229-236.
24. Bruck R, Shirin H, Aeed H, Matas Z, Hochman A, et al. (2001) Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers. J Hepatol 35: 457-464.
25. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD (2009) Liver biopsy. Hepatology 49: 1017-1044.
26. Rockey DC, Bissell DM (2006) Noninvasive measures of liver fibrosis. Hepatology 43: S113-120.
27. Ohta T, Sakaguchi K, Fujiwara A, Fujioka S, Iwasaki Y, et al. (2006) Simple surrogate index of the fibrosis stage in chronic hepatitis C patients using platelet count and serum albumin level. Acta Med Okayama 60: 77-84.
28. Jeong WI, Jeong DH, Do SH, Kim YK, Park HY, et al. (2005) Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats. J Vet Med Sci 67: 235-242.
29. Hope TA, Doherty A, Fu Y, Aslam R, Qayyum A, et al. (2012) Gadolinium Accumulation and Fibrosis in the Liver after Administration of Gadoxetate Disodium in a Rat Model of Active Hepatic Fibrosis. Radiology 264: 423-427.
30. Libra A, Fernetti C, Lorusso V, Visigalli M, Anelli PL, et al. (2006) Molecular determinants in the transport of a bile acid-derived diagnostic agent in tumoral and nontumoral cell lines of human liver. J Pharmacol Exp Ther 319: 809-817.
31. Pascolo L, Cupelli F, Anelli PL, Lorusso V, Visigalli M, et al. (1999) Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun 257: 746-752.
32. Guardigli M, Marangi M, Casanova S, Grigioni WF, Roda E, et al. (2005) Chemiluminescence quantitative immunohistochemical determination of MRP2 in liver biopsies. J Histochem Cytochem 53: 1451-1457.
33. Geier A, Dietrich CG, Voigt S, Kim SK, Gerloff T, et al. (2003) Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 38: 345-354.
34. Tsuda N, Matsui O (2010) Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi-gadoxetic acid-enhanced MR imaging. Radiology 256: 767-773.
35. Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM (2007) Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 5: 1214-1220.
36. Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, et al. (2007) Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 14: 360-369.